Role of ADP-ribosylation in Wnt Pathway Activation
ADP-核糖基化在 Wnt 通路激活中的作用
基本信息
- 批准号:9892659
- 负责人:
- 金额:$ 12.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2020-08-31
- 项目状态:已结题
- 来源:
- 关键词:ADP ribosylationAddressAdenosine Diphosphate RiboseAnimalsBiochemicalBiologicalBiological AssayBiologyCell Differentiation processCellsCollaborationsColorectal CancerComplexCongenital AbnormalityCongenital DisordersCoupledDevelopmentDiseaseDissectionDrosophila genusDrug IndustryEffectivenessEmbryonic DevelopmentGeneticGoalsHeartHumanIn VitroInvertebratesInvestigationKnowledgeLeftLimb structureMalignant NeoplasmsMass Spectrum AnalysisMediatingModelingMultiprotein ComplexesMutagenesisNatureNervous system structurePathway interactionsPhysiologicalPlayPolymerasePost-Translational Protein ProcessingProtein ConformationRegulationResearchRetinaRoleScaffolding ProteinScientistSignal TransductionSignal Transduction PathwaySiteSkeletonSkinSystemTankyraseTestingTherapeutic AgentsTherapeutic InterventionTranscription CoactivatorWNT Signaling PathwayXenopusattenuationbasebeta catenindesigneggexperiencein vivoinhibitor/antagonistinnovationinsightinterestnew therapeutic targetnovelnovel therapeutic interventionpolymerizationpreventprotein complexpublic health relevancereconstitutionrecruitreproductive organresponsescaffoldsmall moleculetherapeutic targettooltreatment strategy
项目摘要
The Wnt signal transduction pathway directs essential steps in embryonic development. Inappropriate
activation of Wnt signaling triggers the development of several cancers, including the vast majority of colorectal
cancers. Thus, understanding the basic mechanisms that underlie Wnt pathway activation will facilitate the
design of innovative strategies for the treatment of a large number of diseases. A major goal of our research is
to elucidate the regulation of two distinct multiprotein complexes - termed the “beta-catenin destruction
complex” and the “signalosome”- that are fundamental for the control of Wnt signaling in the “off” and “on”
states, respectively. Axin, a concentration-limiting scaffold protein, plays important roles in the assembly of
both complexes. How these distinct roles of Axin are coordinated remains a mystery. Regulators of Axin,
including the ADP-ribose polymerase Tankyrase (Tnks) have recently emerged as promising therapeutic
targets. In the current model, the sole role of Tnks is to target Axin for proteasomal degradation, and thereby to
control steady state Axin levels in the unstimulated state. However, we have found, unexpectedly, that ADP-
ribosylation of Axin by Tnks also promotes Axin's critical role in activation of the pathway following Wnt
stimulation. Our findings force major revision of the prevailing model for Tnks function in Wnt signaling and
may underlie the effectiveness of small molecule Tnks inhibitors, which are among the most promising anti-
Wnt pathway agents under development. Thus, in contrast with the prevailing model, we hypothesize that Tnks
plays key roles in controlling Axin activity both in the destruction complex (in the unstimulated state) and in the
signalosome (following Wnt stimulation). We propose to test this hypothesis by analyzing differences in the
state of Axin ADP-ribosylation under basal and Wnt-stimulated conditions. We will determine how Axin ADP-
ribosylation regulates the composition and activity of the β-catenin destruction complex and signalosome. We
will address the physiological roles of ADP-ribosylation on Axin activity in the unstimulated and Wnt-stimulated
states in vivo. These studies are driven by an ongoing collaboration between two scientists who have a shared
interest in Wnt signaling: Yashi Ahmed, an experienced Drosophila geneticist and cell biologist, and Ethan Lee,
an expert in using in vivo approaches in Xenopus and in vitro pathway reconstitution. We will combine our
innovative genetic, cell biological, and biochemical approaches in vertebrate and invertebrate models to
provide insight into the regulation of Wnt signaling. The proposed research has significance for the
development of new therapeutic strategies for Wnt-driven diseases.
Wnt 信号转导途径指导胚胎发育的重要步骤。
Wnt 信号传导的激活会引发多种癌症的发生,包括绝大多数结直肠癌
因此,了解 Wnt 通路激活的基本机制将有助于
设计治疗大量疾病的创新策略是我们研究的一个主要目标。
阐明两种不同的多蛋白复合物的调节——称为“β-连环蛋白破坏”
复合体”和“信号体”——对于控制 Wnt 信号传导的“关闭”和“开启”至关重要
轴蛋白是一种浓度限制的支架蛋白,在组装中发挥重要作用。
Axin 的这些不同作用如何协调仍然是一个谜。
包括 ADP-核糖聚合酶 Tankyrase (Tnks) 最近已成为有前景的治疗药物
在当前模型中,Tnks 的唯一作用是靶向 Axin 进行蛋白酶体降解,从而
控制未刺激状态下的稳态轴蛋白水平然而,我们意外地发现,ADP-
Tnks 对 Axin 的核糖基化还促进 Axin 在 Wnt 之后的通路激活中发挥关键作用
我们的发现迫使对 Wnt 信号传导和 Tnks 功能的流行模型进行重大修改。
可能是小分子 Tnks 抑制剂有效性的基础,小分子 Tnks 抑制剂是最有前途的抗-
因此,与流行的模型相比,我们捕获了 Tnks。
在破坏复合体(未刺激状态)和
我们建议通过分析信号体(Wnt 刺激后)的差异来检验这一假设。
我们将确定 Axin ADP-核糖基化在基础和 Wnt 刺激条件下的状态。
核糖基化调节 β-连环蛋白破坏复合物和信号体的组成和活性。
将解决 ADP-核糖基化对未刺激和 Wnt 刺激的 Axin 活性的生理作用
这些研究是由两位拥有共同观点的科学家之间持续合作推动的。
对 Wnt 信号传导感兴趣:Yashi Ahmed,一位经验丰富的果蝇遗传学家和细胞生物学家,以及 Ethan Lee,
非洲爪蟾体内方法和体外途径重建方面的专家,我们将结合我们的方法。
脊椎动物和无脊椎动物模型中的创新遗传、细胞生物学和生化方法
所提出的研究对于Wnt信号传导的调控具有重要意义。
开发针对 Wnt 驱动疾病的新治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yasmath Ahmed其他文献
Yasmath Ahmed的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yasmath Ahmed', 18)}}的其他基金
A Cereblon signaling network in Wnt-driven cancers
Wnt 驱动的癌症中的 Cereblon 信号网络
- 批准号:
10670555 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Super-resolution spinning disk confocal microscope for Dartmouth Life Sciences
用于达特茅斯生命科学的超分辨率转盘共焦显微镜
- 批准号:
10427997 - 财政年份:2022
- 资助金额:
$ 12.5万 - 项目类别:
Genetic and Molecular Dissection of Wnt Pathway Activation
Wnt 通路激活的遗传和分子剖析
- 批准号:
10163216 - 财政年份:2020
- 资助金额:
$ 12.5万 - 项目类别:
Inhibition of the Wnt Receptor Complex by the Tumor Suppressor Adenomatous Polyposis Coli
抑癌基因腺瘤性息肉病大肠杆菌对 Wnt 受体复合物的抑制
- 批准号:
10063347 - 财政年份:2020
- 资助金额:
$ 12.5万 - 项目类别:
Inhibition of the Wnt Receptor Complex by the Tumor Suppressor Adenomatous Polyposis Coli
抑癌基因腺瘤性息肉病大肠杆菌对 Wnt 受体复合物的抑制
- 批准号:
10217057 - 财政年份:2020
- 资助金额:
$ 12.5万 - 项目类别:
Inhibition of the Wnt Receptor Complex by the Tumor Suppressor Adenomatous Polyposis Coli
抑癌基因腺瘤性息肉病大肠杆菌对 Wnt 受体复合物的抑制
- 批准号:
10653134 - 财政年份:2020
- 资助金额:
$ 12.5万 - 项目类别:
Genetic and Molecular Dissection of Wnt Pathway Activation
Wnt 通路激活的遗传和分子剖析
- 批准号:
10417184 - 财政年份:2020
- 资助金额:
$ 12.5万 - 项目类别:
Inhibition of the Wnt Receptor Complex by the Tumor Suppressor Adenomatous Polyposis Coli
抑癌基因腺瘤性息肉病大肠杆菌对 Wnt 受体复合物的抑制
- 批准号:
10424450 - 财政年份:2020
- 资助金额:
$ 12.5万 - 项目类别:
Role of ADP-ribosylation in Wnt Pathway Activation
ADP-核糖基化在 Wnt 通路激活中的作用
- 批准号:
9383497 - 财政年份:2017
- 资助金额:
$ 12.5万 - 项目类别:
APC Tumor Suppressor in Cell Differentiation and Death
APC 肿瘤抑制因子在细胞分化和死亡中的作用
- 批准号:
9383490 - 财政年份:2017
- 资助金额:
$ 12.5万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
DeADP-ribosylation of host targets mediated by a bacterial effector
由细菌效应子介导的宿主靶标的 DeADP-核糖基化
- 批准号:
10667971 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Identifying the targets of virus-induced PARPs during SARS-CoV-2 infection
识别 SARS-CoV-2 感染期间病毒诱导的 PARP 的靶标
- 批准号:
10573499 - 财政年份:2022
- 资助金额:
$ 12.5万 - 项目类别:
A Chemical Footprinting Approach towards Poly-ADP-Ribosylation-regulated Biomolecular Condensation
聚 ADP 核糖基化调节生物分子缩合的化学足迹方法
- 批准号:
10524783 - 财政年份:2022
- 资助金额:
$ 12.5万 - 项目类别:
Regulation and function of site-specific protein poly-ADP-ribosylation
位点特异性蛋白质聚 ADP 核糖基化的调控和功能
- 批准号:
10668492 - 财政年份:2022
- 资助金额:
$ 12.5万 - 项目类别: